These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 32525783

  • 1. Pharmacovigilance Assessment of Cardiac Implications of Nicotine Replacement Therapy Among Smokers.
    Olawuyi O, Mathieson K.
    Curr Drug Saf; 2020; 15(3):173-180. PubMed ID: 32525783
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study.
    Carney G, Bassett K, Maclure M, Taylor S, Dormuth CR.
    Addiction; 2020 Aug; 115(8):1534-1546. PubMed ID: 32077187
    [Abstract] [Full Text] [Related]

  • 3. Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.
    Evins AE, Benowitz NL, West R, Russ C, McRae T, Lawrence D, Krishen A, St Aubin L, Maravic MC, Anthenelli RM.
    J Clin Psychopharmacol; 2019 Aug; 39(2):108-116. PubMed ID: 30811371
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease.
    Kotz D, Viechtbauer W, Simpson CR, van Schayck OCP, West R, Sheikh A.
    Thorax; 2017 Oct; 72(10):905-911. PubMed ID: 28473506
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.
    Benowitz NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, Lawrence D, St Aubin L, Anthenelli RM.
    JAMA Intern Med; 2018 May 01; 178(5):622-631. PubMed ID: 29630702
    [Abstract] [Full Text] [Related]

  • 6. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
    Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE.
    Lancet; 2016 Jun 18; 387(10037):2507-20. PubMed ID: 27116918
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].
    Sicras Mainar A, Navarro Artieda R, Díaz Cerezo S, Martí Sánchez B, Sanz De Burgoa V.
    Aten Primaria; 2011 Sep 18; 43(9):482-9. PubMed ID: 21382649
    [Abstract] [Full Text] [Related]

  • 9. Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.
    Keeney E, Welton NJ, Stevenson M, Dalili MN, López-López JA, Caldwell DM, Phillippo DM, Munafò MR, Thomas KH.
    Value Health; 2021 Jun 18; 24(6):780-788. PubMed ID: 34119075
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database.
    Kotz D, Simpson C, Viechtbauer W, van Schayck OC, West R, Sheikh A.
    BMJ Open; 2014 Aug 28; 4(8):e005281. PubMed ID: 25168037
    [Abstract] [Full Text] [Related]

  • 11. Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials.
    Nagano T, Katsurada M, Yasuda Y, Kobayashi K, Nishimura Y.
    Ther Adv Respir Dis; 2019 Aug 28; 13():1753466619875925. PubMed ID: 31533544
    [No Abstract] [Full Text] [Related]

  • 12. Comparative Effectiveness of Varenicline and Nicotine Replacement Therapy for Smoking Cessation in Older and Younger Smokers: A Prospective Cohort in Taiwan.
    Chang PY, Shiu MN, Yuan YT, Chang HC, Su PY, Lan TH.
    Nicotine Tob Res; 2019 Jan 04; 21(2):149-155. PubMed ID: 29294121
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia.
    Havard A, Choi SKY, Pearson SA, Chow CK, Tran DT, Filion KB.
    JAMA Netw Open; 2021 Nov 01; 4(11):e2136372. PubMed ID: 34842922
    [Abstract] [Full Text] [Related]

  • 15. Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case-cross-over study.
    Thomas KH, Davies NM, Taylor AE, Taylor GMJ, Gunnell D, Martin RM, Douglas I.
    Addiction; 2021 Jun 01; 116(6):1532-1545. PubMed ID: 33197082
    [Abstract] [Full Text] [Related]

  • 16. In persons smoking after 6 wk of varenicline or combined NRT, increasing dose or switching combined NRT to varenicline increased cessation.
    Lesser LI.
    Ann Intern Med; 2024 Sep 01; 177(9):JC106. PubMed ID: 39222501
    [Abstract] [Full Text] [Related]

  • 17. Moderators of real-world effectiveness of smoking cessation aids: a population study.
    Jackson SE, Kotz D, West R, Brown J.
    Addiction; 2019 Sep 01; 114(9):1627-1638. PubMed ID: 31117151
    [Abstract] [Full Text] [Related]

  • 18. General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.
    Johnson M, Anderson P, Lockhart I.
    BMC Fam Pract; 2014 Mar 20; 15():47. PubMed ID: 24645823
    [Abstract] [Full Text] [Related]

  • 19. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB, Piper ME, Stein JH, Smith SS, Bolt DM, Fraser DL, Fiore MC.
    JAMA; 2016 Jan 26; 315(4):371-9. PubMed ID: 26813210
    [Abstract] [Full Text] [Related]

  • 20. Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial.
    Ebbert J, Jimenez-Ruiz C, Dutro MP, Fisher M, Li J, Hays JT.
    Mayo Clin Proc; 2021 Jul 26; 96(7):1801-1811. PubMed ID: 34112520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.